This means the drug carries a significant risk of serious or even life-threatening adverse effects
Continuous subcutaneous insulin infusion (CSII, see Chapter 10) is associated with a lower frequency of hypoglycemia than multiple insulin injection therapy and should be considered as a therapeutic option in those patients with type 1 diabetes with frequent, unpredictable hypoglycemia
Additionally, the ethical landscape of off-label prescribing is continuously evolving, with new research findings emerging regularly
We do know from the research that high, Adiposity, lots of body fat can impact ovulation in cases of PCOS
GLP-1 receptor agonists are medications that mimic this hormones effects but at a much stronger and longer-lasting level than what the body produces on its own
Only the two highest standard doses, 12.5mg and 15mg, exceed a single syringe capacity